Sanofi Regeneron Deal Turns an $8 Billion Headline Into an Immunology Option
Sanofi will pay Regeneron $1 billion upfront and up to $7 billion in milestones. The structure turns litigation into a staged immunology option—and makes…
Read the story
Sanofi will pay Regeneron $1 billion upfront and up to $7 billion in milestones. The structure turns litigation into a staged immunology option—and makes…
Read the story